Strategies for implementing screening for critical congenital heart disease.
about
Pulse oximetry screening: a review of diagnosing critical congenital heart disease in newbornsUniversal Pulse Oximetry Screening for Early Detection of Critical Congenital Heart DiseaseEvaluating cost and resource use associated with pulse oximetry screening for critical congenital heart disease: Empiric estimates and sources of variation.Selected birth defects data from population-based birth defects surveillance programs in the United States, 2005–2009: Featuring critical congenital heart defects targeted for pulse oximetry screening.Lessons Learned From Newborn Screening for Critical Congenital Heart Defects.Priority target conditions for algorithms for monitoring children's growth: Interdisciplinary consensusCritical congenital heart disease screening by pulse oximetry in a neonatal intensive care unit.Is routine preoperative screening echocardiogram indicated in all children with congenital duodenal obstruction?Pediatric inpatient hospital resource use for congenital heart defects.Detection of critical congenital heart defects: Review of contributions from prenatal and newborn screening.Late detection of critical congenital heart disease among US infants: estimation of the potential impact of proposed universal screening using pulse oximetryCost-effectiveness of routine screening for critical congenital heart disease in US newbornsEstimated number of infants detected and missed by critical congenital heart defect screening.Results from the New Jersey statewide critical congenital heart defects screening programTemporal trends in survival among infants with critical congenital heart defectsHospitalizations, costs, and mortality among infants with critical congenital heart disease: how important is timely detection?Nordic pulse oximetry screening--implementation status and proposal for uniform guidelines.Factors associated with inpatient hospitalizations among patients aged 1 to 64 years with congenital heart defects, Arkansas 2006 to 2011.Next steps for birth defects research and prevention: The birth defects study to evaluate pregnancy exposures (BD-STEPS).Development of a Newborn Screening Program for Critical Congenital Heart Disease (CCHD) in Taipei.Projected growth of the adult congenital heart disease population in the United States to 2050: an integrative systems modeling approach.Factors associated with late detection of critical congenital heart disease in newborns.Feasibility of implementing pulse oximetry screening for congenital heart disease in a community hospital.Current diagnosis and treatments for critical congenital heart defects.Does measurement of four-limb blood pressures at birth improve detection of aortic arch anomalies?Evaluating the diagnostic gap: statewide incidence of undiagnosed critical congenital heart disease before newborn screening with pulse oximetryA public health economic assessment of hospitals' cost to screen newborns for critical congenital heart disease.Pulse oximetry could significantly enhance the early detection of critical congenital heart disease in neonatal intensive care unitsPulse oximetry screening for critical congenital heart disease in planned out of hospital births and the incidence of critical congenital heart disease in the Plain community.A novel, more efficient, staged approach for critical congenital heart disease screening.The utility of outpatient echocardiography for evaluation of asymptomatic murmurs in children.Implications of newborn screening for nurses.Pulse oximetry screening for critical congenital heart defects in newborn infants: should it be routine?The impact of routine predischarge pulse oximetry screening in a regional neonatal unit.Post-implementation review of pulse oximetry screening of well newborns in an Australian tertiary maternity hospital.Identification of Critical Congenital Heart Disease in Vermont: The Role of Universal Pulse Oximetry Screening in a Rural State.Epigenetic markers for newborn congenital heart defect (CHD).Aspects of pulse oximetry screening for critical congenital heart defects: when, how and why?Reliability and Validity of a Smartphone-Paired Pulse Oximeter for Screening of Critical Congenital Heart Defects in Newborns.An Evaluation of the Addition of Critical Congenital Heart Defect Screening in Georgia Newborn Screening Procedures.
P2860
Q26741142-4B5DB593-E835-4E22-A466-6827B4E78997Q26747417-15B9C1B1-F737-469B-A84D-1D70C24E7DFEQ30203057-954FA5A8-38A5-4D3B-A84A-7F3C93DA0314Q30670922-8E19136F-0D1E-4077-A1C4-7F978E64D795Q30834699-B0E9443A-CDB8-47A5-84FC-A819CFF938ACQ33610435-3EAA3E72-72B7-4ED8-BCFC-4BD1035B39A1Q34797807-D65E0A9B-052A-4763-A1CD-70035CF54CDCQ35222614-783B3FAF-408E-492C-83BD-4BD94912C627Q35578662-CBF26DC0-5445-420D-BFD0-5DEC567756A6Q35702543-6D7D026C-C7F6-43C7-A831-15DD99D97AC1Q35751069-46B50353-0E7E-4525-9EED-06D0E3AEAA1CQ35751288-AB88B3F8-9F0B-4853-9D87-5E79990288FBQ35751376-F1C252F5-7963-43E1-8554-7A59138EF11AQ35753537-E303F806-C56A-4FC3-8B8B-6793DB061D36Q35754694-44815B77-97B2-4891-B4A5-3B112C97256BQ35757795-3AED18F6-98F8-4270-B69F-3D10023473F4Q35781193-2AD395F1-5502-4A64-8A0B-D763DC68EC99Q35898146-A4F0B2C2-05CB-40F7-8C8B-DA35F4430CC3Q35957504-5686341B-76AA-41B2-8CE5-CD9181C9A533Q35988411-F26764EE-E066-4A0A-8059-973716F73DD5Q36165092-102F6E6F-E6F6-45A7-BA22-1452C8807BAEQ36198516-AE3A20D9-66F3-45FB-880F-85080B34E98DQ36203549-58E88B13-6FC0-4CF8-BC52-1CEB0A773945Q36824433-08E6377D-5879-4B95-B14D-24279A3F9D3AQ36834909-12CDBE39-28EA-44C8-97E4-61D4F7ABB3F2Q37198507-F5EBCE19-3BF8-4847-AC20-17C16E239FE9Q37391725-1D0DB5DC-1444-4ADD-B7FE-1DD69A4D2F4DQ37394102-14B814C2-E015-459E-825B-ABF04B2AAE6DQ37458939-96E1636E-0E08-44B1-95BE-1D5717C36A17Q37677833-3CC6AE26-E885-4076-BE89-3AF4B081A0F7Q37986092-2105E3EF-709E-4C2B-85B5-7D22F45FE4F1Q38078006-5E7A33F9-4399-4E9A-ACDF-6844F2D06326Q38128220-27DB2E2D-48B8-4E6D-A417-118C9BD99388Q38197402-0A68B9C0-1515-4278-87BC-BE107F0E99A5Q38219826-0958E465-2C69-4A76-A84D-5AC9BD0C1D16Q38268337-92A0C8DA-47E0-46C9-BD8B-91320C452E06Q38456896-5D89A1A0-E8C4-41F4-9DC7-97D914A41A95Q38586594-0B0D2961-F0EC-41C4-8D03-85B00492CF2BQ38646415-0CC84E43-527B-4A6E-B335-74F24B035FC9Q38668776-DBE7BF72-0E23-4579-9DAC-67D864AAE44A
P2860
Strategies for implementing screening for critical congenital heart disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Strategies for implementing screening for critical congenital heart disease.
@en
type
label
Strategies for implementing screening for critical congenital heart disease.
@en
prefLabel
Strategies for implementing screening for critical congenital heart disease.
@en
P2093
P356
P1433
P1476
Strategies for implementing screening for critical congenital heart disease.
@en
P2093
Alex R Kemper
Gail D Pearson
Gerard R Martin
Jill Glidewell
Kellie Kelm
Praveen Kumar
R Rodney Howell
Scott D Grosse
W Carl Cooley
W Robert Morrow
P304
P356
10.1542/PEDS.2011-1317
P407
P577
2011-10-10T00:00:00Z